颜红兵,霍勇

• 1:国家心血管病中心北京协和医学院中国医学科学院阜外医院冠心病中心
• 2:北京大学第一医院心内科

摘要(Abstract)：

《2024年欧洲心脏病学会（ESC）慢性冠状动脉综合征（CCS）诊断和管理指南》的更新体现在：（1）内容和形式的变化；（2）提出了CCS的最新定义；（3）细化了CCS的诊断方法；（4）有关左主干病变或多支病变患者最佳血运重建策略的建议得到了外科的认可；（5）强调要重视微血管功能障碍；（6）更新了有关心绞痛的治疗、抗栓治疗和他汀类等药物治疗的建议。2024年ESC指南的核心是强调要全面处理冠状动脉大血管阻塞和与小血管功能障碍相关的新问题，并强调个体化策略的重要性。

关键词(KeyWords)： 慢性冠状动脉综合征;欧洲心脏病学会

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 颜红兵,霍勇

参考文献(References)：

• [1] Knuuti J, Wijns W, Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3):407-477. DOI:10.1093/eurheartj/ehz425.
• [2]颜红兵，霍勇.《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——冠状动脉疾病治疗：从归类走向精准[J].中国介入心脏病学杂志，2019, 27(9):481-483.DOI:10.3969/j.issn.1004-8812.2019.09.001.
• [3] Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes[J]. Eur Heart J, 2024,45(36):3415-3537. DOI:10.1093/eurheartj/ehae177.
• [4] Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165. DOI:10.1093/eurheartj/ehy394.
• [5] Marzilli M, Crea F, Morrone D, et al. Myocardial ischemia:from disease to syndrome[J]. Int J Cardiol,2020,314:32-35. DOI:10.1016/j.ijcard.2020.04.074.
• [6] Boden WE, Marzilli M, Crea F, et al. Chronic myocardial ischemic syndromes task force. evolving management paradigm for stable ischemic heart disease patients:JACC review topic of the week[J]. J Am Coll Cardiol,2023,81(5):505-514.DOI:10.1016/j.jacc.2022.08.814.
• [7] Stone GW, Kappetein AP, Sabik JF, et al. Five-year outcomes after PCI or CABG for left main coronary disease[J].N Engl J Med,2019,381(19):1820-1830. DOI:10.1056/NEJMoa1909406.
• [8] Sabatine MS, Bergmark BA, Murphy SA, et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease:an individual patient data meta-analysis[J]. Lancet,2021,398(10318):2247-2257. DOI:10.1016/S0140-6736(21)02334-5.
• [9] Sucato V, Madaudo C, Galassi AR. The ANOCA/INOCA dilemma considering the 2024 ESC guidelines on chronic coronary syndromes[J]. J Cardiovasc Dev Dis,2024, 11(10):302. DOI:10.3390/jcdd11100302.
• [10] Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for coronary artery revascularization:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J].J Am Coll Cardiol,2022,79(2):e21-e129. DOI:10.1016/j.jacc.2021.09.006.
• [11] Virani SS, Newby LK, Arnold SV,et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with chronic coronary disease:a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines[J].Circulation,2023,148(9):e9-e119. DOI:10.1161/CIR.0000000000001168.
• [12] Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease[J]. N Engl J Med,2020,382(15):1395-1407. DOI:10.1056/NEJMoa1915922.
• [13] Sabik JF 3rd, Bakaeen FG, Ruel M,et al. The American Association for Thoracic Surgery and the Society of Thoracic Surgeons reasoning for not endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines[J]. J Thorac Cardiovasc Surg,2022,163(4):1362-1365. DOI:10.1016/j.jtcvs.2021.12.025.
• [14] Navarese EP, Lansky AJ, Kereiakes DJ, et al. Cardiac mortality inpatients randomised to electivecoronary revascularisation plus medical therapy or medical therapy alone:a systematic review and meta-analysis[J]. Eur Heart J,2021,42(45):4638-4651. DOI:10.1093/eurheartj/ehab246.
• [15] Hochman JS, Anthopolos R, Reynolds HR, et al. Survival after invasive or conservative management of stable coronary disease[J]. Circulation,2023,147(1):8-19. DOI:10.1161/CIRCULATIONAHA.122.062714.
• [16]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国慢性冠脉综合征患者诊断及管理指南[J].中华心血管病杂志，2024,52(6):589-614. DOI:10.3760/cma.j.cn112148-20240325-00168.
• [17] Ueng KC, Chiang CE, Chao TH, et al. 2023 Guidelines of the Taiwan society of cardiology on the diagnosis and management of chronic coronary syndrome[J]. Acta Cardiol Sin,2023,39(1):4-96. DOI:10.6515/ACS.202301_39(1).20221103A.
• [18] Jing T, Wang Y, Li Y, et al. Diagnosis, treatment, and management for chronic coronary syndrome:a systematic review of clinical practice guidelines and consensus statements[J]. Int J Clin Pract,2023,2023:9504108. DOI:10.1155/2023/9504108.
• [19] Boden WE, De Caterina R, Kaski JC, et al. Myocardial ischaemic syndromes:a new nomenclature to harmonize evolving international clinical practice guidelines[J]. Eur Heart J,2024,45(36):3701-3706. DOI:10.1093/eurheartj/ehae278.
• [20]颜红兵，霍勇.从欧美指南看稳定性冠心病诊断术语的演变[J].中国介入心脏病学杂志，2024,32(11):631-634.DOI:10.3969/j.issn.1004-8812.2024.11.004.